The key enzymes BCAT, BCKDH, and BCKDK, along with mTOR and MEK-ERK signaling, are central to BCAA metabolic regulation in disease contexts (61)
New England Journal of Medicine , 387(3), 205-216
Mega Doctor News By George Washington University Newswise A major shift is coming to the GLP-1 weight loss drug market in 2026 one that could dramatically change who can access these medications, how theyre taken, and how much they cost
As for the GLP-1 albumin fusions, exposure to CPA resulted in removal of L585 and reduced FcRn binding of the WT albumin fusions, but not for the QMP-engineered counterparts (Supplementary Fig
wHAT IT IS GLP-1 medications are typically administered through injections prescribed by a licensed medical practitioner
Educate, inspire, and stay top-of-mind with content that builds credibility and motivates potential patients